Diversified Healthcare Trust
DHCReal Estate·REIT - Healthcare Facilities·USA·Small·NASD·Nov 13 • 7:45 AM ET
Price
DHC against its 20, 50 and 200-day averages23.8% under the 52-week high of 9.66 on 30 Jun 2026. 52-week low 4.34 on 21 Nov 2025. Last 15 sessions, 19.7% high to low
Volume 0.00× normal · the line is the 50-bar volume average
Setup. RS line 73
CANSLIM 5 of 6 — fails: 52-Week High/Low: 0-10% below High
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 1 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 2 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Yield: Over 2%; Dividend Growth: Growing 2+ Years — not on the tape: Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Float: Under 100M; 200-Day Simple Moving Average: Price above SMA200
Accumulation 2 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
DHCDiversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the Medical Office and Life Science Portfolio and SHOP segments. The Medical Office and Life Science Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that provide short term and long-term residential living and, in some instances, care and other services for residents where pay fees to managers to operate the communities. The company was founded on December 16, 1998 and is headquartered in Newton, MA.
| Index | RUT |
|---|---|
| IPO | Oct 07, 1999 |
| Beta | 2.29 |
| ATR, 14d | 0.28 |
| Rel volume | 0.00 |
| Short float | 5.51% |
| Insider own | 10.24% |
| Inst own | 84.81% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $1.79B |
| Enterprise Value | 4.07B |
| Income | -152.14M |
| Sales | 1.48B |
| Book / share | 6.31 |
| Cash / share | 0.54 |
| Dividend Est. | 0.04 (0.54%) |
| Dividend TTM | 0.04 (0.54%) |
| Dividend Ex-Date | Oct 19, 2026 |
| Dividend Gr. 3/5Y | 0.00% -25.98% |
| Payout | - |
| Employees | - |
| IPO | Oct 07, 1999 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 1.21 |
| Price / book | 1.17 |
| Price / cash | 13.63 |
| Price / free cash flow | - |
| Value / cash profit | 17.41 |
| Value / sales | 2.75 |
| Quick Ratio | 8.88 |
| Current Ratio | 8.88 |
| Debt / equity | 1.58 |
| Long-term debt / equity | 1.58 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.63 |
|---|---|
| Earnings next year | -0.40 |
| Earnings next quarter | -0.14 |
| Earnings this year | 44.26% |
| Earnings next year | 39.20% |
| Earnings growth, 5 years | 31.65% |
| Past earnings growth | -161.94% -15.19% |
| Past sales growth | 6.21% -1.18% |
| Earnings vs last year | 56.90% |
| Sales vs last year | -3.82% |
| Earnings vs last quarter | 69.46% |
| Sales vs last quarter | -5.41% |
| Earnings | Nov 02 AMC |
| Surprise | 184.00% -0.86% |
Ownership
| Insiders own | 10.24% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 84.81% |
| Institution trades | 5.36% |
| Return on assets | -3.43% |
| Return on equity | -9.45% |
| Return on capital | -3.85% |
| Gross Margin | 4.28% |
| Operating margin | -1.11% |
| Profit Margin | -10.29% |
| 20-day average | -2.54% |
| 50-day average | -4.11% |
| 200-day average | -6.28% |
Technical
| Shares out | 242.56M |
|---|---|
| Shares floating | 217.70M |
| Short / float | 5.51% |
| Short ratio | 6.73 |
| Short interest | 11.99M |
| 52-week high | 9.66 -23.8% |
| 52-week low | 4.34 +69.6% |
| Volatility | 3.51% 3.92% |
| Average range | 0.28 |
| Strength index | 44.02 |
| Market sensitivity | 2.29 |
| Relative volume | 0.00 |
| Avg Volume | 1.78M |
| Volume | 34 |
Performance
| Perf Week | 4.84% |
|---|---|
| Perf Month | -3.29% |
| Perf Quarter | -11.22% |
| Perf Half Y | -11.96% |
| Perf YTD | 51.75% |
| Perf Year | 54.30% |
| Perf 3Y | 273.60% |
| Perf 5Y | 115.20% |
| Perf 10Y | -56.90% |
| Recommendation | 1.80 |
| Target Price | 9.88 |
| Prev Close | 7.29 |
| Price | 7.36 |
| Change % | 0.96% |
Analyst ratings
latest 6 of 6| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Apr 27, 2026 | Initiated | Maxim Group | Buy | $9.50 | +29.1% |
| Nov 13, 2025 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform | $5 | -32.1% |
| Apr 03, 2025 | Resumed | B. Riley Securities | Buy | $4.50 | -38.9% |
| Dec 10, 2020 | Downgrade | Wells Fargo | Equal Weight → Underweight | $4 | -45.7% |
| Jun 08, 2020 | Resumed | JMP Securities | Mkt Perform | ||
| Jan 17, 2020 | Downgrade | Wells Fargo | Overweight → Equal Weight | $9 | +22.3% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| AHR | American Healthcare REIT Inc | 13.58B |
| NHI | National Health Investors Inc | 3.13B |
| VTR | Ventas Inc | 48.43B |
| LTC | LTC Properties Inc | 2.47B |
| SBRA | Sabra Healthcare REIT Inc | 5.32B |
| WELL | Welltower Inc | 180.44B |
| NHP | National Healthcare Properties Inc | 1.11B |
| DOC | Healthpeak Properties Inc | 14.17B |
| HR | Healthcare Realty Trust Inc | 6.49B |
| JAN | Janus Living Inc | 9.98B |
Insider trading
1 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Bilotto Christopher J. | President and CEO | Dec 15 '25 | Buy | 4.89 | 20,000 | 97,720 | 266,285 | Dec 16 04:44 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VNQ | Vanguard Real Estate Index Fund ETF | AUM: 39.24B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWN | iShares Russell 2000 Value ETF | AUM: 14.17B |
| SCHH | Schwab U.S. REIT ETF | AUM: 11.93B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| DFAR | DFA Real Estate Securities Portfolio ETF Class Shares | AUM: 1.82B |
| FESM | Fidelity Enhanced Small Cap Core ETF | AUM: 6.90B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
News
latest 14 of 200- Diversified Healthcare Trust Misses And Cuts FFO Guidance, But The Cut Is An Accounting Change While SHOP Fundamentals Improve (Earnings Whispers)
- Diversified Healthcare: Q3 Earnings Snapshot (Associated Press)
- Diversified Healthcare Trust Announces Third Quarter 2026 Results (Business Wire)
- Diversified Healthcare Trust Must Show Its Margin Story Can Survive Slower Occupancy Gains (Earnings Whispers)
- The RMR Group Announces $272 Million Refinancing of Cedars-Sinai Medical Office Portfolio in Los Angeles (Business Wire)
- Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares (Business Wire)
- Diversified Healthcare Trust Third Quarter 2026 Conference Call Scheduled for Tuesday, November 3rd (Business Wire)
- Diversified Healthcare Trust Announces 15-Year Net Lease with The Ensign Group for Colorado Skilled Nursing Portfolio (Business Wire)
- Industrial Logistics Properties Trust Appoints Anthony Paula as Chief Financial Officer and Treasurer (Business Wire)
- Diversified Healthcare Trust (DHC) (Q2 2026) Earnings Call Highlights: SHOP NOI Surges 37% as ... (GuruFocus.com)
- Diversified Healthcare: Q2 Earnings Snapshot (Associated Press)
- Diversified Healthcare Trust Announces Second Quarter 2026 Results (Business Wire)
- Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares (Business Wire)
- Diversified Healthcare Trust Second Quarter 2026 Conference Call Scheduled for Tuesday, August 4th (Business Wire)
Quarterly earnings
2026Q3 EPS 0.126 beat -0.150, from 0.043 a year earlier. Sales 367.67 missed 370.87, from 388.71 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-02 16:30 | 0.126 | -0.150 | -0.210 | 367.67 | 370.87 | EPS -184.0% · sales -0.9% | vs 2025Q3, year-ago quarter · EPS +194.4% · sales -5.4% | 3 EPS · 5 sales | Open -8.40% vs SPY +0.08%. Close -2.45% vs SPY +0.30% |
| 2026Q2ended 2026-06-30 | 2026-08-03 16:30 | -0.160 | -0.147 | -0.155 | 365.39 | 370.76 | EPS +9.1% · sales -1.4% | vs 2025Q2, year-ago quarter · EPS -302.5% · sales -4.5% | 3 EPS · 5 sales | Open -1.25% vs SPY +0.39%. Close -0.11% vs SPY +1.80% |
| 2026Q1ended 2026-03-31 | 2026-05-04 16:30 | -0.180 | -0.157 | -0.180 | 366.47 | 380.18 | EPS +14.9% · sales -3.6% | vs 2025Q1, year-ago quarter · EPS -415.2% · sales -5.3% | 3 EPS · 4 sales | Open -0.26% vs SPY +0.52%. Close +5.28% vs SPY +0.80% |
| 2025Q4ended 2025-12-31 | 2026-02-23 16:30 | -0.090 | -0.175 | -0.088 | 379.57 | 392.89 | EPS -48.6% · sales -3.4% | vs 2024Q4, year-ago quarter · EPS -75.0% · sales 0.0% | 2 EPS · 3 sales | Open -0.81% vs SPY -0.07%. Close -0.81% vs SPY +0.73% |
| 2025Q3ended 2025-09-30 | 2025-11-03 16:30 | 0.043 | -0.215 | -0.682 | 388.71 | 382.31 | EPS -119.9% · sales +1.7% | vs 2024Q3, year-ago quarter · EPS +130.1% · sales +4.0% | 2 EPS · 3 sales | Open -5.66% vs SPY -1.06%. Close -4.86% vs SPY -1.19% |
| 2025Q2ended 2025-06-30 | 2025-08-04 16:30 | 0.079 | -0.220 | -0.382 | 382.71 | 380.62 | EPS -135.9% · sales +0.6% | vs 2024Q2, year-ago quarter · EPS -117.9% · sales +3.0% | 2 EPS · 3 sales | Open -1.17% vs SPY +0.10%. Close +0.59% vs SPY -0.51% |
| 2025Q1ended 2025-03-31 | 2025-05-05 16:30 | 0.057 | -0.250 | -0.037 | 386.86 | 383.17 | EPS -122.8% · sales +1.0% | vs 2024Q1, year-ago quarter · EPS -116.6% · sales +4.3% | 2 EPS · 3 sales | Open +10.09% vs SPY -0.99%. Close +31.19% vs SPY -0.84% |
| 2024Q4ended 2024-12-31 | 2025-02-25 16:30 | -0.360 | -0.290 | -0.364 | 379.62 | 370.97 | EPS +24.1% · sales +2.3% | vs 2023Q4, year-ago quarter · EPS +10.7% · sales +5.0% | 1 EPS · 2 sales | Open +0.82% vs SPY +0.28%. Close +8.57% vs SPY +0.05% |
| 2024Q3ended 2024-09-30 | 2024-11-04 16:30 | 0.019 | - | -0.412 | 373.64 | 380.17 | EPS - · sales -1.7% | vs 2023Q3, year-ago quarter · EPS -107.0% · sales +4.8% | 3 | Open -5.40% vs SPY +0.16%. Close -19.60% vs SPY +1.21% |
| 2024Q2ended 2024-06-30 | 2024-08-01 16:30 | -0.442 | -0.280 | -0.409 | 371.39 | 372.13 | EPS +58.0% · sales -0.2% | vs 2023Q2, year-ago quarter · EPS +54.1% · sales +7.3% | 1 EPS · 2 sales | Open -6.08% vs SPY -1.34%. Close -1.22% vs SPY -1.86% |
| 2024Q1ended 2024-03-31 | 2024-05-06 16:30 | -0.343 | -0.280 | -0.361 | 370.78 | 370.65 | EPS +22.5% · sales +0.0% | vs 2023Q1, year-ago quarter · EPS +78.0% · sales +7.2% | 1 EPS · 3 sales | Open -3.91% vs SPY +0.19%. Close -9.77% vs SPY +0.11% |
| 2023Q4ended 2023-12-31 | 2024-02-26 16:30 | -0.325 | -0.250 | -0.429 | 361.54 | 360.99 | EPS +30.1% · sales +0.2% | vs 2022Q4, year-ago quarter · EPS +37.3% · sales +7.3% | 1 EPS · 2 sales | Open +0.33% vs SPY +0.14%. Close +7.00% vs SPY +0.19% |
| 2023Q3ended 2023-09-30 | 2023-11-01 16:30 | -0.264 | - | -0.275 | 356.52 | 359.78 | EPS - · sales -0.9% | vs 2022Q3, year-ago quarter · EPS -13.8% · sales +10.4% | 1 | - |
| 2023Q2ended 2023-06-30 | 2023-08-01 16:30 | -0.287 | -0.220 | -0.304 | 346.22 | 353.15 | EPS +30.5% · sales -2.0% | vs 2022Q2, year-ago quarter · EPS -4.7% · sales +10.6% | 1 | - |
| 2023Q1ended 2023-03-31 | 2023-05-08 16:30 | -0.193 | -0.230 | -0.221 | 346.03 | 341.33 | EPS -16.2% · sales +1.4% | vs 2022Q1, year-ago quarter · EPS -40.6% · sales +11.4% | 1 EPS · 3 sales | - |
| 2022Q4ended 2022-12-31 | 2023-03-01 16:30 | -0.237 | -0.280 | -0.274 | 336.89 | 330.4 | EPS -15.4% · sales +2.0% | vs 2021Q4, year-ago quarter · EPS -26.8% · sales +0.0% | 1 EPS · 4 sales | - |
Annual earnings
2025FY EPS -1.190 beat -1.275, from -1.550 a year earlier. Sales 1,538 missed 1,551, from 1,495 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2028FYestimate | - | -0.380 | - | - | 1,652 | - |
| 2027FYestimate | - | -0.403 | - | - | 1,547 | - |
| 2026FYestimate | - | -0.663 | - | - | 1,475 | - |
| 2025FY | -1.190 | -1.275 | -1.190 | 1,538 | 1,551 | - |
| 2024FY | -1.550 | -1.470 | -1.546 | 1,495 | 1,486 | - |
| 2023FY | -1.128 | -1.050 | -1.229 | 1,410 | 1,410 | - |
| 2022FY | -1.201 | -0.070 | -0.066 | 1,284 | 1,277 | - |
| 2021FY | -1.088 | -1.040 | 0.733 | 1,383 | 1,382 | - |
| 2020FY | -0.378 | -0.653 | -0.587 | 1,632 | 1,636 | - |
| 2019FY | -0.370 | -0.130 | -0.371 | 1,040 | 1,036 | - |
| 2018FY | 1.174 | 1.885 | 1.208 | 1,117 | 1,120 | 9.63 |
| 2017FY | 0.442 | 0.502 | 0.622 | 1,075 | 1,074 | 41.81 |
| 2016FY | 0.636 | 0.582 | -0.612 | 1,058 | 1,055 | 28.72 |
| 2015FY | 0.505 | 0.660 | 0.532 | 998.77 | 994.72 | 14.58 |
| 2014FY | 0.760 | 0.776 | 0.776 | 844.89 | 844.39 | 9.69 |
| 2013FY | 0.767 | 0.747 | 0.786 | 761.44 | 761.67 | 9.60 |
| 2012FY | 0.833 | 0.830 | 0.776 | 644.84 | 631.88 | 8.84 |
| 2011FY | 0.980 | 0.970 | 0.980 | 422.17 | 428.03 | 7.51 |
| 2010FY | 0.990 | 0.925 | 0.883 | 339.01 | 334.61 | 7.43 |
Quarterly results
2026Q3 revenue 367.67, from 388.71 a year earlier. Operating margin 0.0%, from -4.1% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.66 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-06 | -0.66 | +1.0% |
| 2026Q4 | E | per share | 2026-11-06 | -0.14 | -4.5% |
| 2026FY | S | USD millions | 2026-11-06 | 1,475 | 0.0% |
| 2026Q4 | S | - | 2026-11-06 | 373.28 | +0.1% |
| 2026FY | R | per share | 2026-11-03 | -0.69 | +16.9% |
| 2026Q4 | R | per share | 2026-11-03 | -0.15 | +15.4% |
| 2026Q3 | E | per share | 2026-10-19 | -0.15 | 0.0% |
| 2026Q3 | R | per share | 2026-10-18 | -0.13 | 0.0% |
| 2026Q3 | S | - | 2026-10-18 | 370.87 | 0.0% |
| 2026Q2 | E | per share | 2026-07-19 | -0.15 | 0.0% |
| 2026Q2 | S | - | 2026-07-19 | 370.76 | 0.0% |
| 2026Q2 | R | per share | 2026-06-02 | -0.15 | -6.3% |
| 2026Q1 | E | per share | 2026-04-24 | -0.16 | +4.5% |
| 2026Q1 | R | per share | 2026-04-24 | -0.17 | - |
| 2026Q1 | S | - | 2026-04-24 | 380.18 | +0.7% |
| 2025FY | E | per share | 2026-02-07 | -1.28 | 0.0% |
| 2025Q4 | E | per share | 2026-02-07 | -0.18 | 0.0% |
| 2025FY | S | USD millions | 2026-02-07 | 1,551 | 0.0% |
| 2025Q4 | S | - | 2026-02-07 | 392.89 | 0.0% |
| 2025Q3 | S | - | 2025-10-25 | 382.3 | 0.0% |
| 2025Q3 | E | per share | 2025-10-20 | -0.22 | 0.0% |
| 2025Q2 | E | per share | 2025-08-02 | -0.22 | 0.0% |
| 2025Q2 | S | - | 2025-08-02 | 380.79 | 0.0% |
| 2025Q1 | E | per share | 2025-04-04 | -0.25 | -10.7% |
| 2025Q1 | S | - | 2025-04-04 | 383.17 | +0.5% |
| 2024FY | S | USD millions | 2025-02-09 | 1,486 | 0.0% |
| 2024Q4 | S | - | 2025-02-09 | 370.97 | 0.0% |
| 2024FY | E | per share | 2024-12-27 | -1.47 | 0.0% |
| 2024Q4 | E | per share | 2024-12-27 | -0.29 | 0.0% |
| 2024Q3 | S | - | 2024-11-03 | 380.17 | 0.0% |
| 2024Q3 | E | per share | 2024-08-02 | -0.26 | 0.0% |
| 2024Q2 | S | - | 2024-06-23 | 372.13 | -0.3% |
| 2024Q2 | E | per share | 2024-06-06 | -0.28 | +3.7% |
| 2024Q1 | S | - | 2024-03-19 | 370.65 | +0.1% |
| 2024Q1 | E | per share | 2024-03-17 | -0.28 | 0.0% |
| 2023FY | E | per share | 2024-01-02 | -1.05 | +1.0% |
| 2023FY | S | USD millions | 2023-12-29 | 1,410 | +0.1% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.622 | 1.208 | -0.371 | -0.587 | 0.733 | -0.066 | -1.229 | -1.546 | -1.19 | -0.6318 | - |
| Sales USD millions | 409 | 431 | 1,040 | 1,632 | 1,383 | 1,284 | 1,410 | 1,495 | 1,538 | 1,479 | - |
| Shares million shares | 238 | 238 | 238 | 238 | 239 | 240 | 240 | 241 | 242 | - | 243 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.412 | -0.364 | -0.037 | -0.382 | -0.682 | -0.088 | -0.18 | -0.155 | -0.208 |
| Sales USD millions | 374 | 380 | 387 | 383 | 389 | 380 | 366 | 365 | 368 |
| Shares million shares | 241 | 241 | 241 | 241 | 242 | 242 | 242 | 242 | 243 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,479.10 | 1,537.85+2.8% | 1,495.43+6.0% | 1,410.31+9.9% | 1,283.57-7.2% | 1,383.21-15.2% | 1,632.03+56.9% | 1,040.15+141.5% | 430.75 |
| Total Expenses | 1,495.51 | 1,577.12+1.7% | 1,550.53+4.3% | 1,487.09+6.0% | 1,403.05-3.7% | 1,456.77-3.1% | 1,503.81+81.6% | 828.23-1.9% | 844.62 |
| Operating Income | -16.41 | -39.27 | -55.10 | -76.78 | -119.48 | -73.56-157.4% | 128.22-39.5% | 211.93 | -413.87 |
| Unusual Expense | -9.41 | 200.71+182.5% | 71.06+268.8% | 19.27-25.1% | 25.72+1048.2% | 2.24-97.3% | 84.50-26.7% | 115.25+73.6% | 66.37 |
| Net Income Before Taxes | -180.75 | -320.90 | -371.38 | -272.67 | -21.12-111.6% | 181.36 | -133.06 | -82.84-128.3% | 292.37 |
| Income Taxes | 3.16 | 1.74+270.2% | 0.47+4.4% | 0.45-36.6% | 0.71-50.3% | 1.43+14.4% | 1.25+184.1% | 0.44-8.3% | 0.48 |
| Consolidated Net Income | -152.14 | -285.89 | -370.25 | -293.57 | -15.77-108.8% | 179.93 | -134.31 | -82.88-128.3% | 292.41 |
| Net Income From Continuing Operations | -152.14 | -285.89 | -370.25 | -293.57 | -15.77-109.0% | 174.51 | -139.45 | -88.23-130.8% | 286.87 |
| Net Income | -152.14 | -285.89 | -370.25 | -293.57 | -15.77-109.0% | 174.51 | -139.45 | -88.23-130.8% | 286.87 |
| EPS (Recurring) per share | -0.66 | -0.61 | -1.34 | -1.17-11800.0% | 0.01-98.6% | 0.74 | -0.34 | -0.03-102.1% | 1.40 |
| EPS (Basic, Before Extraordinaries) per share | -0.63 | -1.19 | -1.55 | -1.23 | -0.07-109.6% | 0.73 | -0.59 | -0.37-130.6% | 1.21 |
| EPS (Diluted) per share | -0.63 | -1.19 | -1.55 | -1.23 | -0.07-109.6% | 0.73 | -0.59 | -0.37-130.6% | 1.21 |
| Non-Operating Income (Expense) | 13.39 | 123.53 | -9.99-165.9% | 15.16-95.5% | 333.46-35.0% | 512.91+1975.7% | 24.71+4160.3% | 0.58-99.8% | 265.48 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 2.69+24.0% | 2.17+49.7% | 1.45+5.8% | 1.37-4.2% | 1.43+25.4% | 1.14+37.3% | 0.83 | -1.33 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | 0.37 | 4.22 | - | - | 108.19 |
| Price To Sales Ratio ratio | 1.28 | 0.76 | 0.37 | 0.63 | 0.12 | 0.53 | 0.60 | 1.93 | 6.46 |
| Gross Margin % | 4.28 | 1.08 | -1.74 | -3.40 | -5.05 | 1.47 | 7.69 | 25.19 | -71.29 |
| Operating Margin % | -1.11 | -2.55 | -3.68 | -5.44 | -9.31 | -5.32 | 7.86 | 20.37 | -96.08 |
| Net Margin % | -10.29 | -18.59 | -24.76 | -20.82 | -1.23 | 12.62 | -8.54 | -8.48 | 66.60 |
| Shares Outstanding million shares | 242.56 | 242.12+0.4% | 241.27+0.4% | 240.42+0.3% | 239.69+0.3% | 238.99+0.3% | 238.27+0.2% | 237.90+0.1% | 237.73 |
| Market Capitalization | 1,768.04 | 1,768.04+218.6% | 554.93-38.3% | 899.28+480.0% | 155.04-79.0% | 738.49-24.8% | 981.66-49.6% | 1,948.06-27.9% | 2,703.21 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 367.67-5.4% | 365.39-4.5% | 366.47-5.3% | 379.570.0% | 388.71+4.0% | 382.71+3.0% | 386.86+4.3% | 379.62+5.0% |
| Total Expenses | 367.71-9.1% | 365.90-6.2% | 371.20-5.2% | 390.69-0.3% | 404.66+3.0% | 390.10+2.5% | 391.68+1.6% | 391.71-0.6% |
| Operating Income | -0.04 | -0.52 | -4.73 | -11.12 | -15.95 | -7.39 | -4.81 | -12.09 |
| Unusual Expense | -14.54-113.9% | 0.00-100.0% | 0.00-100.0% | 5.13-82.4% | 104.43+353.5% | 31.12+361.0% | 60.02+394.4% | 29.13+1995.7% |
| Net Income Before Taxes | -52.21 | -37.97 | -42.75 | -47.81 | -168.79 | -93.88 | -10.42 | -98.96 |
| Income Taxes | 0.72+111.8% | 1.30+54.8% | 0.62+1140.0% | 0.51 | 0.34+126.7% | 0.84+394.1% | 0.05-73.7% | -0.04-157.1% |
| Consolidated Net Income | -50.23 | -37.42 | -43.27 | -21.22 | -164.04 | -91.64 | -8.99 | -87.45 |
| Net Income From Continuing Operations | -50.23 | -37.42 | -43.27 | -21.22 | -164.04 | -91.64 | -8.99 | -87.45 |
| Net Income | -50.23 | -37.42 | -43.27 | -21.22 | -164.04 | -91.64 | -8.99 | -87.45 |
| EPS (Recurring) per share | -0.25 | -0.16 | -0.18-228.6% | -0.07 | -0.38 | -0.29 | 0.14 | -0.28 |
| EPS (Basic, Before Extraordinaries) per share | -0.21 | -0.16 | -0.18 | -0.09 | -0.68 | -0.38 | -0.04 | -0.36 |
| EPS (Diluted) per share | -0.21 | -0.16 | -0.18 | -0.09 | -0.68 | -0.38 | -0.04 | -0.36 |
| Non-Operating Income (Expense) | -0.50-202.0% | -0.41 | -0.99-100.9% | 15.28+763.3% | 0.49-81.8% | -4.45 | 112.24 | 1.77-39.8% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price To Sales Ratio ratio | 1.28 | 1.49 | 1.05 | 0.76 | 0.69 | 0.56 | 0.38 | 0.37 |
| Gross Margin % | 4.87 | 5.99 | 3.55 | 2.77 | -0.52 | 1.01 | 1.09 | -3.44 |
| Operating Margin % | -0.01 | -0.14 | -1.29 | -2.93 | -4.10 | -1.93 | -1.24 | -3.18 |
| Net Margin % | -13.66 | -10.24 | -11.81 | -5.59 | -42.20 | -23.94 | -2.32 | -23.04 |
| Shares Outstanding million shares | 242.56+0.2% | 242.19+0.3% | 242.11+0.3% | 242.12+0.4% | 242.15+0.4% | 241.42+0.3% | 241.27+0.4% | 241.27+0.4% |
| Market Capitalization | 1,768.04+66.1% | 2,251.60+160.7% | 1,607.68+177.7% | 1,174.41+111.6% | 1,064.64+5.6% | 863.68+17.7% | 578.97-2.1% | 554.93-38.3% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 121.80-18.7% | 149.85-39.3% | 246.96-64.1% | 688.30-32.3% | 1,016.95+1019.4% | 90.85+74.0% | 52.22-25.5% | 70.07+48.1% | 47.32 |
| Short Term Receivables | 66.14-10.5% | 73.87-9.2% | 81.39-4.3% | 85.08+3.6% | 82.13 | 0.00-100.0% | 1.99-89.4% | 18.70+0.9% | 18.54 |
| Investments | 3,858.90-11.1% | 4,340.48-9.5% | 4,797.62-1.5% | 4,870.07-4.6% | 5,107.29-11.8% | 5,789.60-1.7% | 5,892.36-9.1% | 6,483.94-0.8% | 6,533.04 |
| Investment in Unconsolidated Affiliates | 147.33-5.3% | 155.50+14.3% | 136.00-17.2% | 164.19-23.7% | 215.13+2151200.0% | 0.01-96.7% | 0.30+1400.0% | 0.02-99.8% | 8.19 |
| Net Property, Plant & Equipment | 16.54-17.4% | 20.02-14.3% | 23.37-11.8% | 26.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 150.55-62.1% | 397.27+147.1% | 160.80-4.3% | 167.94-15.1% | 197.87-66.6% | 591.73-16.3% | 706.96+20.3% | 587.70-14.4% | 686.94 |
| Total Assets | 4,361.25-15.1% | 5,137.01-5.7% | 5,446.14-9.3% | 6,002.09-9.4% | 6,623.51+2.3% | 6,476.42-2.7% | 6,653.83-7.1% | 7,160.43-1.8% | 7,294.02 |
| Total Debt | 2,417.94-17.5% | 2,931.61+3.2% | 2,841.07-7.6% | 3,075.88-16.5% | 3,683.43+3.1% | 3,571.05-0.2% | 3,578.37-4.2% | 3,734.72-0.9% | 3,770.54 |
| Long Term Debt | 2,416.07-5.2% | 2,549.67-10.2% | 2,839.25+1.1% | 2,809.47-22.9% | 3,644.36+11.5% | 3,267.89+4.6% | 3,124.57-5.0% | 3,288.58-12.8% | 3,770.54 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 277.74+12.7% | 246.55-8.1% | 268.18-6.8% | 287.60+3.6% | 277.69-3.0% | 286.15+44.2% | 198.41-19.3% | 245.84-0.2% | 246.29 |
| Total Liabilities | 2,695.68-15.2% | 3,178.16+2.2% | 3,109.24-7.6% | 3,363.48-15.1% | 3,961.12+2.7% | 3,857.20+2.1% | 3,776.78-5.1% | 3,980.56-0.9% | 4,016.83 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,665.57-15.0% | 1,958.84-16.2% | 2,336.89-11.4% | 2,638.61-0.9% | 2,662.39+6.7% | 2,495.84-8.8% | 2,736.52-9.5% | 3,023.11-2.6% | 3,104.95 |
| Total Shareholders Equity | 1,665.57-15.0% | 1,958.84-16.2% | 2,336.89-11.4% | 2,638.61-0.9% | 2,662.39+6.7% | 2,495.84-8.8% | 2,736.52-9.5% | 3,023.11-2.6% | 3,104.95 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 123.39-12.2% | 140.53-10.4% | 156.76-9.0% | 172.24 |
| Total Equity | 1,665.57-15.0% | 1,958.84-16.2% | 2,336.89-11.4% | 2,638.61-0.9% | 2,662.39+1.6% | 2,619.22-9.0% | 2,877.05-9.5% | 3,179.87-3.0% | 3,277.19 |
| Total Liabilities & Stockholders Equity | 4,361.25-15.1% | 5,137.01-5.7% | 5,446.14-9.3% | 6,002.09-9.4% | 6,623.51+2.3% | 6,476.42-2.7% | 6,653.83-7.1% | 7,160.43-1.8% | 7,294.02 |
| Book Value Per Share per share | 6.88-15.3% | 8.12-16.5% | 9.72-11.7% | 11.01-1.2% | 11.14+6.4% | 10.47-9.0% | 11.50-9.6% | 12.72-2.7% | 13.07 |
| Tangible Book Value Per Share per share | 6.79-15.2% | 8.01-16.4% | 9.58-11.5% | 10.82-1.1% | 10.94+18.0% | 9.27-8.0% | 10.08-7.9% | 10.95-1.2% | 11.08 |
| Price to Book Ratio ratio | 1.16 | 0.27 | 0.37 | 0.06 | 0.28 | 0.39 | 0.71 | 0.89 | 1.42 |
| Return on Assets % | -6.02 | -7.00 | -5.13 | -0.25 | 2.66 | -2.12 | -1.28 | 3.97 | 2.03 |
| Return on Equity % | -15.78 | -17.24 | -11.80 | -0.60 | 6.77 | -5.33 | -3.06 | 9.36 | 4.68 |
| Return on Invested Capital % | -7.00 | -8.21 | -5.67 | -0.29 | 2.77 | -2.42 | -1.51 | 4.55 | 2.15 |
| Quick Ratio ratio | 3.71 | 1.19 | 10.64 | 2.57 | 14.24 | 0.57 | 0.53 | 0.17 | 0.78 |
| Current Ratio ratio | 3.71 | 1.19 | 10.64 | 2.57 | 14.24 | 0.57 | 0.53 | 0.17 | 0.78 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Funds from Operations | 81.10 | -4.48-104.3% | 105.41+175.1% | 38.32 | -41.99-2432.8% | 1.80-99.0% | 172.01-46.8% | 323.16-17.1% | 389.74 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 21.30 | 33.26+387.7% | 6.82 | -27.84-1797.6% | 1.64 | -65.12 | -13.18 | -50.88-1741.3% | 3.10 |
| Cash from Operating Activities | 102.41 | 28.78-74.4% | 112.22+970.8% | 10.48 | -40.35 | -63.31-139.9% | 158.83-41.7% | 272.27-30.7% | 392.84 |
| Capital Expenditures | -118.66 | -146.82 | -201.70 | -235.01 | -299.39 | -227.60 | -185.59 | -222.42 | -103.80 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 98.56 | 0.00 |
| Purchase or Sale of Investments | 225.83 | 580.73+1941.9% | 28.44+54.9% | 18.36-97.3% | 672.63+43.0% | 470.29+224.7% | 144.86-28.9% | 203.60+0.3% | 202.90 |
| Purchase of Investments | -14.52 | -8.50 | -5.72 | 0.00 | -75.11 | 0.00 | -2.53 | -50.64 | -129.49 |
| Sale Or Maturity of Investments | 240.34 | 589.23+1624.4% | 34.17+86.1% | 18.36-97.5% | 747.73+59.0% | 470.29+219.1% | 147.39-42.0% | 254.24-23.5% | 332.39 |
| Other Uses | -0.19 | -0.05 | -15.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 1.31-22.9% | 1.70-88.3% | 14.54+0.5% | 14.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 106.98 | 435.17 | -187.02 | -202.11-152.1% | 387.71+59.8% | 242.69 | -40.72-151.1% | 79.75-19.5% | 99.09 |
| Cash Dividends Paid | -9.68 | -9.66 | -9.63 | -9.60 | -9.57 | -9.54 | -42.83 | -199.72 | -370.75 |
| Change in Capital Stock | -2.78 | -1.15 | -0.90 | -0.39 | -0.17 | -0.38 | -0.17 | -0.30 | -0.41 |
| Repurchase of Common Pref Stock | -2.78 | -1.15 | -0.90 | -0.39 | -0.17 | -0.38 | -0.17 | -0.30 | -0.41 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -269.65 | -443.54 | -11.78 | -238.75 | -639.07-182.0% | 778.99 | -13.82 | -1,142.35-397.1% | 384.44 |
| Change in Long Term Debt | 480.35 | 310.31 | -8.56-101.8% | 478.30 | -639.07 | 0.00 | -542.88 | -696.00 | - |
| Issuance of Long Term Debt | -372.40 | 320.93+188.0% | 111.44-84.7% | 728.30 | 0.00 | 0.00-100.0% | 425.12 | - | - |
| Reduction of Long Term Debt | 852.74 | -10.62 | -120.00 | -250.00 | -639.07 | 0.00 | -968.00 | -696.00 | - |
| Net Financing Active Other Cash Flow | -0.25 | 0.00 | 0.00 | 0.00 | -27.19 | -32.70 | -22.67 | -21.58 | -21.17 |
| Other Financing Activities Uses | -2.11 | -37.66 | 0.00 | -0.98 | -27.19 | -32.70 | -22.67 | -21.58 | -21.17 |
| Cash from Financing Activities | -288.06 | -492.01 | -22.31 | -249.71 | -676.00-190.5% | 746.72 | -79.48 | -369.86 | -469.18 |
| Net Change in Cash | -78.68 | -28.05 | -97.11 | -441.34 | -328.64-135.5% | 926.10+2298.0% | 38.62 | -17.85-178.5% | 22.75 |
| Free Cash Flow | -16.25 | -118.04 | -89.48 | -224.52 | -339.74 | -290.92 | -26.75-153.7% | 49.85-82.8% | 289.04 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 130.95-37.5% | 136.20-8.3% | 139.85-54.4% | 121.80-18.7% | 209.62-19.8% | 148.58-45.0% | 306.65+47.3% | 149.85-39.3% |
| Short Term Receivables | 61.91-0.2% | 62.02-11.1% | 62.22-11.1% | 66.14-10.5% | 62.06-16.2% | 69.75-7.0% | 69.95-6.4% | 73.87-9.2% |
| Investments | 3,717.82-4.2% | 3,936.56-5.2% | 3,818.89-10.3% | 3,858.90-11.1% | 3,882.36-14.9% | 4,153.64-10.8% | 4,255.09-9.6% | 4,340.48-9.5% |
| Investment in Unconsolidated Affiliates | 122.98+1.6% | 120.87-18.1% | 119.62-15.6% | 147.33-5.3% | 121.01-9.9% | 147.57+10.4% | 141.76-2.9% | 155.50+14.3% |
| Net Property, Plant & Equipment | 13.80-20.8% | 14.72-19.6% | 15.64-18.4% | 16.54-17.4% | 17.42-16.5% | 18.30-15.7% | 19.17-15.0% | 20.02-14.3% |
| Other Intangible Assets | 141.96-63.7% | -31.67-114.5% | 111.34-45.2% | 150.55-62.1% | 391.50+68.3% | 218.60+22.8% | 203.22+8.3% | 397.27+147.1% |
| Total Assets | 4,189.41-10.6% | 4,238.70-10.9% | 4,267.55-14.6% | 4,361.25-15.1% | 4,683.97-11.4% | 4,756.44-10.8% | 4,995.84-6.6% | 5,137.01-5.7% |
| Total Debt | 2,418.22-11.8% | 2,417.93-8.9% | 2,417.59-14.3% | 2,417.94-17.5% | 2,741.18-7.6% | 2,655.20-9.7% | 2,819.95-1.4% | 2,931.61+3.2% |
| Long Term Debt | 2,417.91+0.5% | 2,417.32-9.0% | 2,416.52-14.3% | 2,416.07-5.2% | 2,405.75-18.9% | 2,655.20-9.7% | 2,819.95-1.4% | 2,549.67-10.2% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 241.30-5.0% | 237.93-3.4% | 229.54+0.7% | 277.74+12.7% | 254.07-6.0% | 246.27+1.7% | 227.84-4.5% | 246.55-8.1% |
| Total Liabilities | 2,659.52-11.2% | 2,655.87-8.5% | 2,647.13-13.1% | 2,695.68-15.2% | 2,995.24-7.5% | 2,901.47-8.9% | 3,047.79-1.7% | 3,178.16+2.2% |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,529.88-9.4% | 1,582.83-14.7% | 1,620.42-16.8% | 1,665.57-15.0% | 1,688.73-17.6% | 1,854.97-13.7% | 1,948.05-13.4% | 1,958.84-16.2% |
| Total Shareholders Equity | 1,529.88-9.4% | 1,582.83-14.7% | 1,620.42-16.8% | 1,665.57-15.0% | 1,688.73-17.6% | 1,854.97-13.7% | 1,948.05-13.4% | 1,958.84-16.2% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 1,529.88-9.4% | 1,582.83-14.7% | 1,620.42-16.8% | 1,665.57-15.0% | 1,688.73-17.6% | 1,854.97-13.7% | 1,948.05-13.4% | 1,958.84-16.2% |
| Total Liabilities & Stockholders Equity | 4,189.41-10.6% | 4,238.70-10.9% | 4,267.55-14.6% | 4,361.25-15.1% | 4,683.97-11.4% | 4,756.44-10.8% | 4,995.84-6.6% | 5,137.01-5.7% |
| Book Value Per Share per share | 6.31-9.5% | 6.54-14.8% | 6.69-17.1% | 6.88-15.3% | 6.97-17.9% | 7.68-14.0% | 8.07-13.7% | 8.12-16.5% |
| Tangible Book Value Per Share per share | 6.23-9.4% | 6.46-14.9% | 6.61-17.1% | 6.79-15.2% | 6.88-17.8% | 7.59-13.8% | 7.97-13.6% | 8.01-16.4% |
| Price to Book Ratio ratio | 1.16 | 1.39 | 0.97 | 0.70 | 0.57 | 0.44 | 0.30 | 0.27 |
| Return on Assets % | -3.43 | -5.91 | -6.91 | -6.02 | -7.06 | -5.68 | -5.66 | -7.00 |
| Return on Equity % | -9.45 | -15.47 | -17.94 | -15.78 | -18.84 | -14.32 | -13.96 | -17.24 |
| Return on Invested Capital % | -1.27 | -0.94 | -1.07 | -0.52 | -4.01 | -2.03 | -0.19 | -1.94 |
| Quick Ratio ratio | 8.88 | 6.65 | 7.75 | 3.71 | 1.45 | 10.88 | 16.95 | 1.19 |
| Current Ratio ratio | 8.88 | 6.65 | 7.75 | 3.71 | 1.45 | 10.88 | 16.95 | 1.19 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Funds from Operations | 29.66 | 28.36-6.3% | 23.43 | -0.35-101.0% | -32.75-279.9% | 30.27+9.2% | -1.66-106.5% | 34.03+217.7% |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.27 | 10.02-56.0% | -15.08 | 28.64 | -16.54-664.5% | 22.75+37.4% | -1.58-150.0% | -15.84 |
| Cash from Operating Activities | 27.39 | 38.38-27.6% | 8.34 | 28.29+55.4% | -49.28-333.2% | 53.02+19.7% | -3.24-111.3% | 18.20 |
| Capital Expenditures | -26.87 | -24.18 | -35.17 | -32.43 | -40.56 | -34.18 | -39.65 | -66.74 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00-100.0% | -14.56-210.9% | 48.89-85.2% | 191.50+31816.7% | 46.67+127.3% | 13.13+229.9% | 329.44+9763.5% | 0.60-95.9% |
| Purchase of Investments | 0.00 | -14.56 | 0.00 | 0.05 | 0.00 | -2.75 | -5.80 | -5.72 |
| Sale Or Maturity of Investments | 0.00-100.0% | 0.00-100.0% | 48.89-85.4% | 191.45+2929.3% | 46.67+127.3% | 15.87+298.7% | 335.24+9937.1% | 6.32-57.3% |
| Other Uses | 0.00 | 0.00 | -0.15 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00-100.0% | 1.31 | 0.00-100.0% |
| Cash from Investing Activities | -26.87-539.1% | -38.75 | 13.58-95.3% | 159.02 | 6.12 | -21.05 | 291.09 | -66.14 |
| Cash Dividends Paid | -2.42 | -2.42 | -2.42 | -2.42 | -2.41 | -2.41 | -2.41 | -2.41 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -2.56 | -0.05 | -0.09 | -0.08 | -0.95 | -0.10 | -0.01 | -0.00 |
| Repurchase of Common Pref Stock | -2.56 | -0.05 | -0.09 | -0.08 | -0.95 | -0.10 | -0.01 | -0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.79-100.7% | -0.82 | -1.36 | -270.77 | 117.48 | -187.52-462.9% | -102.73 | -57.97-295.1% |
| Change in Long Term Debt | 0.00-100.0% | 0.00 | 0.00 | 480.35 | 118.55 | -186.70-461.3% | -101.89 | -57.97-112.1% |
| Issuance of Long Term Debt | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -372.40 | 363.36 | 193.30+71.9% | 136.67 | -0.36-100.0% |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 852.74 | -244.81 | -380.00 | -238.56 | -57.61 |
| Net Financing Active Other Cash Flow | 0.00 | -0.08 | -0.17 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% |
| Other Financing Activities Uses | 0.00 | -0.08 | -0.17 | -1.86 | -9.90 | 0.00 | -25.90 | - |
| Cash from Financing Activities | -5.77-105.5% | -3.29 | -3.87 | -275.13 | 104.21 | -190.04-448.8% | -131.05 | -63.60-341.5% |
| Net Change in Cash | -5.25-108.6% | -3.66 | 18.05-88.5% | -87.82 | 61.04 | -158.07-355.3% | 156.80 | -111.55 |
| Free Cash Flow | 0.52 | 14.20-24.6% | -26.82 | -4.14 | -89.84 | 18.84+472.6% | -42.89 | -48.54 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Rental Income | 251.04 | 225.20 | -10.3% | 14.6% |
| Resident Fees And Services | 1,244.39 | 1,312.66 | +5.5% | 85.4% |
| Total | 1,495.43 | 1,537.85 | +2.8% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 1,495.43 | 1,537.85 | +2.8% | 100.0% |
| Total | 1,495.43 | 1,537.85 | +2.8% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Consolidation, Policy | 37.72 | 31.39 | -16.8% | 2.0% |
| Medical Office and Life Science Portfolio | 213.32 | 193.81 | -9.1% | 12.6% |
| Senior Housing Operating Portfolio | 1,244.39 | 1,312.66 | +5.5% | 85.4% |
| Total | 1,495.43 | 1,537.85 | +2.8% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 5.51% | 12.0M | 217.7M | 1.85M |
| 2026-10-15 | 5.40% | 11.7M | 217.3M | 1.82M |
| 2026-09-30 | 5.38% | 11.7M | 217.3M | 1.68M |
| 2026-09-15 | 6.17% | 13.4M | 217.3M | 1.67M |
| 2026-08-31 | 5.94% | 12.9M | 217.5M | 1.75M |
| 2026-08-14 | 6.08% | 13.2M | 217.5M | 1.86M |
| 2026-07-31 | 6.30% | 13.7M | 217.5M | 1.73M |
| 2026-07-15 | 5.75% | 12.5M | 217.4M | 1.72M |
| 2026-06-30 | 5.58% | 12.1M | 217.4M | 1.77M |
| 2026-06-15 | 4.78% | 10.2M | 212.4M | 1.79M |
| 2026-05-29 | 3.96% | 8.6M | 217.5M | 1.85M |
| 2026-05-15 | 4.30% | 9.3M | 217.5M | 1.91M |
| 2026-04-30 | 4.51% | 9.8M | 217.5M | 1.94M |
| 2026-04-15 | 4.32% | 9.4M | 217.0M | 2.11M |
| 2026-03-31 | 4.02% | 8.7M | 217.0M | 2.10M |
| 2026-03-13 | 3.47% | 7.5M | 217.0M | 1.83M |
| 2026-02-27 | 2.87% | 6.2M | 217.0M | 1.54M |
| 2026-02-13 | 2.53% | 5.5M | 216.9M | 1.34M |
| 2026-01-30 | 2.70% | 5.9M | 217.5M | 1.23M |
| 2026-01-15 | 2.74% | 6.0M | 217.5M | 970.74K |
Option chain
Expiry 2026-11-20 · underlying 7.36, quoted 13 Nov 07:45 ET · ATM 7.50
Option quotes 9 Nov 10:20 ET. A date on a row is older than the last session (12 Nov). 12 rows.
Implied move 11.55% into expiry (call 0.400 + put 0.450 = 0.850 on 7.36)
Put/call open interest 0.50 (2 puts / 4 calls) · Put/call volume — no calls
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 1 Jan | 2.50 | ITM | 4.20 | 5.40 | 0.00 | 0.00 | 918.0% +483.4 | 0 | 0 | 0 | 0.977 | -0.016 | 0.001 |
| put 1 Jan | OTM | 0.00 | 0.75 | 0.00 | 0.00 | 434.7% 0.0 | 0 | 0 | 0 | -0.023 | -0.016 | 0.001 | |
| call 9 Nov | 5.00 | ITM | 2.10 | 2.60 | 2.20 | 0.00 | 310.0% +133.2 | 1 | 0 | 0 | 0.944 | -0.014 | 0.001 |
| put 22 Oct | OTM | 0.00 | 0.05 | 0.02 | 0.00 | 451.1% 0.0 | 1 | 0 | 0 | -0.184 | -0.078 | 0.003 | |
| call 26 Oct | 7.50 | ATM | 0.00 | 0.80 | 1.60 | 0.00 | 208.8% +8.8 | 2 | 0 | 0 | 0.521 | -0.055 | 0.004 |
| put 28 Oct | ATM | 0.00 | 0.90 | 0.05 | 0.00 | 184.3% -15.7 | 1 | 0 | 0 | -0.479 | -0.054 | 0.004 | |
| call 22 Oct | 10.00 | OTM | 0.00 | 0.10 | 0.03 | 0.00 | 222.3% 0.0 | 1 | 0 | 0 | 0.237 | -0.045 | 0.004 |
| put 1 Jan | ITM | 2.20 | 3.30 | 0.00 | 0.00 | 322.1% +153.7 | 0 | 0 | 0 | -0.876 | -0.023 | 0.002 | |
| call 1 Jan | 12.50 | OTM | 0.00 | 0.05 | 0.00 | 0.00 | 197.8% 0.0 | 0 | 0 | 0 | 0.058 | -0.015 | 0.001 |
| put 1 Jan | ITM | 4.70 | 5.80 | 0.00 | 0.00 | 420.1% +207.7 | 0 | 0 | 0 | -0.942 | -0.015 | 0.001 | |
| call 1 Jan | 15.00 | OTM | 0.00 | 0.75 | 0.00 | 0.00 | 265.5% 0.0 | 0 | 0 | 0 | 0.049 | -0.018 | 0.001 |
| put 1 Jan | ITM | 7.10 | 8.50 | 0.00 | 0.00 | 547.1% +281.6 | 0 | 0 | 0 | -0.951 | -0.017 | 0.001 |
Latest SEC filings
30 of 56310-Q filed 2026-11-02, period ended 2026-09-30. 10-K filed 2026-02-24, period ended 2025-12-31. DHC on EDGAR
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-02 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001075415-26-000039 index |
| 2026-11-02 | 8-K | All annual, quarterly, and current reports | 2026-11-02 | 0001075415-26-000037 index |
| 2026-09-21 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-17 · transaction | 0001104659-26-109321 index |
| 2026-09-21 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-17 · transaction | 0001104659-26-109315 index |
| 2026-09-21 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-17 · transaction | 0001104659-26-109312 index |
| 2026-09-14 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-10 · transaction | 0001104659-26-107581 index |
| 2026-09-14 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-10 · transaction | 0001104659-26-107580 index |
| 2026-09-14 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-10 · transaction | 0001104659-26-107579 index |
| 2026-08-14 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0001799456-26-000010 index |
| 2026-08-12 | SCHEDULE 13D/A | Beneficial ownership reports | no report period | 0001687639-26-000001 index |
| 2026-08-03 | 10-Q | All annual, quarterly, and current reports | 2026-06-30 | 0001075415-26-000030 index |
| 2026-08-03 | 8-K | All annual, quarterly, and current reports | 2026-08-03 | 0001075415-26-000029 index |
| 2026-07-28 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002012383-26-002473 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073498 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073497 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073495 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073494 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073491 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073490 index |
| 2026-06-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-10 · transaction | 0001104659-26-073486 index |
| 2026-06-12 | 8-K | All annual, quarterly, and current reports | 2026-06-10 | 0001104659-26-073447 index |
| 2026-06-01 | 8-K | All annual, quarterly, and current reports | 2026-06-01 | 0001104659-26-068894 index |
| 2026-05-05 | 8-K | All annual, quarterly, and current reports | 2026-05-05 | 0001104659-26-055290 index |
| 2026-05-04 | 10-Q | All annual, quarterly, and current reports | 2026-03-31 | 0001075415-26-000024 index |
| 2026-05-04 | 8-K | All annual, quarterly, and current reports | 2026-05-04 | 0001075415-26-000022 index |
| 2026-03-26 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0000102909-26-001197 index |
| 2026-03-25 | DEFA14A | Proxy materials | no report period | 0001104659-26-034612 index |
| 2026-03-19 | DEFA14A | Proxy materials | no report period | 0001104659-26-032084 index |
| 2026-03-19 | DEF 14A | Proxy materials | 2026-06-10 | 0001104659-26-032082 index |
| 2026-03-19 | ARS | Proxy materials | 2025-12-31 | 0001104659-26-032079 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 97.72K | 1 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Flat Footed LLC | 9.70% |
| BlackRock, Inc. | 9.53% |
| Silver Point Capital L.P. | 6.40% |
| H/2 CREDIT MANAGER LP | 5.29% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.38% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.00% |
| STATE STREET CORP | 3.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.89% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 2.65% |
| NOMURA HOLDINGS INC | 2.59% |
Funds
| Fund | % owned |
|---|---|
| Lord Abbett Short Duration High Yield Fund | 7.31% |
| Intrepid Income Fund | 6.61% |
| PGIM Total Return Bond Fund | 4.99% |
| iShares Broad USD High Yield Corporate Bond ETF | 4.23% |
| BlackRock High Yield Portfolio | 4.01% |
| Lord Abbett High Yield Fund | 3.91% |
| PIMCO High Yield Fund | 3.31% |
| iShares iBoxx $ High Yield Corporate Bond ETF | 3.31% |
| VANGUARD REAL ESTATE INDEX FUND | 3.14% |
| PGIM Floating Rate Income Fund | 3.11% |
OakChart. DHC. Cached 15 minutes. Terms